Learn More

CBD oil is growing in popularity in the United States and around the world. We encourage you to learn more about CBD and it's potential benefits by reading some of the resources we have provided below. 


CBS News did an quick look into CBD and some of the potential benefits in a piece with Dr. Tara Narula.

This short video provides a quick overview: 



NPR did an investigation into CBD and some of the ongoing research into it's uses and effects. 



For those that want to see some of the research, there are a number of studies that have been done on CBD oil and many more ongoing.


Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents

This review looks at the pharmacology and toxicology of CBD. It also finds that CBD has "several pharmacologic activities that give it a high potential for therapeutic use. CBD exhibits neuroprotective, antiepileptic, anxiolytic, antipsychotic, and antinflammatory properties."


Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Pius S. Fasinu, Sarah Phillips, Mahmoud A. ElSohly, Larry A. Walker
Pharmacotherapy. 2016 Jul; 36(7): 781–796. doi: 10.1002/phar.1780


Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.

This study took 24 people and give half of them CBD and half of them a placebo in a double blind experiment. They were then asked to give a public speech and were measure on a number of physiological measures  (blood pressure, heart rate, and skin conductance) as well as some self-reported questions about their anxiety and stress levels. 

The participants who took the CBD rated lower on both measures for anxiety and stress. This was true both in anticipation of the speech, during the speech, and even after the speech. Some cool charts in this study as well.

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Mateus M Bergamaschi, Regina Helena Costa Queiroz, Marcos Hortes Nisihara Chagas, Danielle Chaves Gomes de Oliveira, Bruno Spinosa De Martinis, Flávio Kapczinski, João Quevedo, Rafael Roesler, Nadja Schröder, Antonio E Nardi, Rocio Martín-Santos, Jaime Eduardo Cecílio Hallak, Antonio Waldo Zuardi, José Alexandre S Crippa
Neuropsychopharmacology. 2011 May; 36(6): 1219–1226. Published online 2011 Feb 9. doi: 10.1038/npp.2011.6


Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

This article is a summary of a number of presentations at a conference on the effects of CBD on epilepsy. Although scientists do not yet know why CBD seems to help with epilespy some theories include "equilibrative nucleoside transporter; the orphan G-protein-coupled receptor GPR55; the transient receptor potential of vanilloid type-1 channel; the 5-HT1a receptor; and the α3 and α1 glycine receptors."

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley, Daniel Friedman
Published in final edited form as: Epilepsia. 2014 Jun; 55(6): 791–802. Published online 2014 May 22. doi: 10.1111/epi.12631